COLORECTAL CANCER

Value of SATB2 immunostaining in the distinction between small intestinal and colorectal adenocarcinomas
Christopher J Kim, Tamar Baruch-Oren, Fan Lin, Xuemo (Sean) Fan, Ximing J Yang, Hanlin L Wang

Journal of Clinical Pathology Dec 2016, 69 (12) 1046-1050; DOI: 10.1136/jclinpath-2015-203588
Ectopic crypt foci in conventional and serrated colorectal polyps
Sara A Väyrynen, Juha P Väyrynen, Kai Klintrup, Jyrki Mäkelä, Anne Tuomisto, Markus J Mäkinen

Journal of Clinical Pathology Dec 2016, 69 (12) 1063-1069; DOI: 10.1136/jclinpath-2015-203593
Circulating cell-free DNA in serum as a biomarker of colorectal cancer
Benisio Ferreira da Silva Filho, Ana Pavla Almeida Diniz Gurgel, Manoel Álvaro de Freitas Lins Neto, Dalmo Almeida de Azevedo, Antonio Carlos de Freitas, Jacinto da Costa Silva Neto, Luiz Antonio Ferreira Silva

Journal of Clinical Pathology Sep 2013, 66 (9) 775-778; DOI: 10.1136/jclinpath-2013-201521
miR-181a is associated with poor clinical outcome in patients with colorectal cancer treated with EGFR inhibitor
Martin Pichler, Elke Winter, Anna Lena Ress, Thomas Bauernhofer, Armin Gerger, Tobias Kiesslich, Sigurd Lax, Hellmut Samonigg, Gerald Hoefler

Journal of Clinical Pathology Mar 2014, 67 (3) 198-203; DOI: 10.1136/jclinpath-2013-201904
Correlation between DPYD gene variation and KRAS wild type status in colorectal cancer
Britta Kleist, Marcel Kempa, Thuja Meurer, Micaela Poetsch

Journal of Clinical Pathology Mar 2016, 69 (3) 204-208; DOI: 10.1136/jclinpath-2015-202903
Smad4 inactivation predicts for worse prognosis and response to fluorouracil-based treatment in colorectal cancer
Margaret M Kozak, Rie von Eyben, Jonathan Pai, Stephen R Vossler, Maneesha Limaye, Priya Jayachandran, Eric M Anderson, Jenny L Shaffer, Teri Longacre, Reetesh K Pai, Albert C Koong, Daniel T Chang

Journal of Clinical Pathology May 2015, 68 (5) 341-345; DOI: 10.1136/jclinpath-2014-202660
Pre-trial inter-laboratory analytical validation of the FOCUS4 personalised therapy trial
Susan D Richman, Richard Adams, Phil Quirke, Rachel Butler, Gemma Hemmings, Phil Chambers, Helen Roberts, Michelle D James, Sue Wozniak, Riya Bathia, Cheryl Pugh, Timothy Maughan, Bharat Jasani

Journal of Clinical Pathology Jan 2016, 69 (1) 35-41; DOI: 10.1136/jclinpath-2015-203097
Frequent BRAF mutation in early-onset colorectal cancer in Taiwan: association with distinct clinicopathological and molecular features and poor clinical outcome
Jia-Huei Tsai, Jau-Yu Liau, Yu-Lin Lin, Li-Hui Tseng, Liang-In Lin, Kun-Huei Yeh, Yung-Ming Jeng

Journal of Clinical Pathology Apr 2016, 69 (4) 319-325; DOI: 10.1136/jclinpath-2015-203335
Reporting trends of right-sided hyperplastic and sessile serrated polyps in a large teaching hospital over a 4-year period (2009–2012)
Pelvender Gill, Lai Mun Wang, Adam Bailey, James E East, Simon Leedham, Runjan Chetty

Journal of Clinical Pathology Aug 2013, 66 (8) 655-658; DOI: 10.1136/jclinpath-2013-201608
The role of lymph node size and FOXP3+ regulatory T cells in node-negative colon cancer
Bruno Märkl, Beate Paul, Tina Schaller, Hallie Kretsinger, Bernadette Kriening, Gerhard Schenkirsch

Journal of Clinical Pathology May 2017, 70 (5) 443-447; DOI: 10.1136/jclinpath-2016-203978

Main menu

COLORECTAL CANCER

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

COLORECTAL CANCER

Pages